FHL1 and laryngeal carcinoma: In contrast, the expression of Fhl1 is upregulated in cancers such as laryngeal carcinomas, gastric signet ring cell carcinoma, lung adenocarcinoma, gastric cancer, acute promyelocytic leukemia, and glioblastoma, among others.